A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/15/2009	CA2248417C Pharmaceutical compositions suitable for use against histomoniasis
12/15/2009	CA2226833C Adenovirus vectors for gene therapy
12/15/2009	CA2209315C Gibberellins compounds for veterinary and medicinal applications
12/15/2009	CA2186763C Use of substituted dextranes for treating nervous system damage, and heparane sulphate-enriched fractions
12/15/2009	CA2171226C Treatment of optic nerve disorder with prostanoic acid compounds
12/15/2009	CA2139168C Food supplements for very young kids
12/13/2009	CA2668527A1 Novel azabicyclic derivatives, process for preparing them and pharmaceutical compounds containing them
12/12/2009	WO2009151495A2 Oxazole compounds, compositions and methods of use
12/10/2009	WO2009149441A1 Aldosterone induced vascular elastin production
12/10/2009	WO2009149436A1 Substituted aminothiazole prodrugs of compounds with anti-hcv activity
12/10/2009	WO2009149435A2 Promoting axon regeneration in the adult cns through control of protein translation
12/10/2009	WO2009149344A2 Solid states of aliskiren free base
12/10/2009	WO2009149306A2 Complement depleting compounds and methods of treating cancer comprising monoclonal antibody therapy and said complement depleting compounds
12/10/2009	WO2009149258A2 Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
12/10/2009	WO2009149239A1 Methods of modulating angiogenesis via trpv4
12/10/2009	WO2009149192A1 Stat3 inhibitors
12/10/2009	WO2009149188A1 Compounds and methods for treating inflammatory and fibrotic disorders
12/10/2009	WO2009149176A1 6-substituted estradiol derivatives and methods of use
12/10/2009	WO2009149155A1 Microbial-derived chondroitin sulfate
12/10/2009	WO2009149150A2 Composition comprising liposome-entrapped doxorubicin and methods of administration
12/10/2009	WO2009149149A1 Prevention or treatment of immune-relevant disease by modification of microfloral populations
12/10/2009	WO2009149141A1 Injectable and infusable mercury compositions and methods for treating cancer
12/10/2009	WO2009149139A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/10/2009	WO2009149135A1 Bis (hetero ) aryl substituted isoxazoles for use as neuronal nicotinic receptor modulators
12/10/2009	WO2009149081A1 Method for treating inflammatory conditions
12/10/2009	WO2009149066A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
12/10/2009	WO2009149058A2 Modified release niacin formulations
12/10/2009	WO2009149056A2 Combinations of niacin and an oxicam
12/10/2009	WO2009149054A1 Small molecule inhibitors for the treatment or prevention of dengue virus infection
12/10/2009	WO2009149053A2 Naproxcinod process and solid dispersion
12/10/2009	WO2009149003A1 Sofinicline (abt-894 ) for attention-deficit/hyperactivity disorder
12/10/2009	WO2009148990A1 Pulsatile release of valsartan
12/10/2009	WO2009148961A2 Drugs to prevent hpv infection
12/10/2009	WO2009148916A1 Inhibitors of akt activity
12/10/2009	WO2009148891A1 Treatment for neurological and mental disorders
12/10/2009	WO2009148875A1 Oral compositions containing enhanced antibacterial combinations of antioxidants and extracts of magnolia
12/10/2009	WO2009148874A2 Gamma-lactam compounds for promoting bone growth
12/10/2009	WO2009148730A1 Method for inhibiting the growth of bacteria
12/10/2009	WO2009148709A1 Pharmacological targeting of vascular malformations
12/10/2009	WO2009148659A2 Antimalarial quinolines and methods of use thereof
12/10/2009	WO2009148654A2 Cephalotaxus esters, methods of synthesis, and uses thereof
12/10/2009	WO2009148623A2 Methods and related compositions for the treatment of cancer
12/10/2009	WO2009148620A2 Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
12/10/2009	WO2009148605A2 Methods for treating hypercholesterolemia
12/10/2009	WO2009148600A2 Deuterated lysine-based compounds
12/10/2009	WO2009148599A1 Pyrrole compunds that modulate hsp90 activity
12/10/2009	WO2009148584A1 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
12/10/2009	WO2009148580A2 Controlled release copolymer formulation with improved release kinetics
12/10/2009	WO2009148571A1 Inhibition of quorum sensing-mediated processes in bacteria
12/10/2009	WO2009148564A1 Selenophene and selenazole carboxylic acid derivatives
12/10/2009	WO2009148536A1 Method of treating burns using avermectin compound
12/10/2009	WO2009148405A1 Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide
12/10/2009	WO2009148403A1 Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators
12/10/2009	WO2009148348A1 Method for controlling infections and tumoral diseases by suppressing multidrug resistance
12/10/2009	WO2009148315A1 Method for preventing corticosteroid usage
12/10/2009	WO2009148291A2 3- or 4-substituted piperidine compounds
12/10/2009	WO2009148290A2 3-substituted propanamine compounds
12/10/2009	WO2009148287A2 Novel α-iso-cubebene compound extracted from schisandra chinensis and composition containing the compound as active ingredient for preventing and treating inflammatory diseases
12/10/2009	WO2009148280A2 Diaryl hepatonoid-based compound useful as virus inhibitor
12/10/2009	WO2009148279A2 Triterpenoid-based compound used as a virus inhibitor
12/10/2009	WO2009148218A2 Composition for the treatment of arthritis containing a dibenzo-p-dioxin derivative as the active ingredient
12/10/2009	WO2009148192A1 Alpha helix mimetics and methods relating thereto
12/10/2009	WO2009148163A1 Agent for contracting bladder detrusor muscle and relaxing urethral sphincter muscle
12/10/2009	WO2009148137A1 Nucleic acid capable of controlling degranulation of mast cell
12/10/2009	WO2009148059A1 Cream-like o/w type emulsified composition and method for producing same
12/10/2009	WO2009148052A1 Sulfonamide compound and application thereof
12/10/2009	WO2009148004A1 Novel compound and pharmaceutical application of same
12/10/2009	WO2009147990A1 Novel isoxazole derivative
12/10/2009	WO2009147984A1 Dna encoding polypeptide involved in biosynthesis of herboxidiene
12/10/2009	WO2009147843A1 Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
12/10/2009	WO2009147831A1 Method and pharmaceutical composition for treatment of mental disorders
12/10/2009	WO2009147781A1 Antitumor agent
12/10/2009	WO2009147742A1 Sirna of human osteopontin
12/10/2009	WO2009147695A1 Anticancer agent
12/10/2009	WO2009147681A1 Pharmaceutical compositions for treatment of parkinson's disease
12/10/2009	WO2009147679A1 Use of fts for the treatment of myocardial ischemia/reperfusion injury
12/10/2009	WO2009147665A1 Process for manufacture of a medicament with granulation and pan coating
12/10/2009	WO2009147637A1 Compositions comprising amino acids, with pro-angiogenic activity
12/10/2009	WO2009147635A1 Fulvic acid and antibiotic combination
12/10/2009	WO2009147632A2 New compounds for the treatment of cancer
12/10/2009	WO2009147616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
12/10/2009	WO2009147529A1 Substantially pure deferasirox and processes for the preparation thereof
12/10/2009	WO2009147476A1 Novel pde inhibitors, pharmaceutical compositions containing them and processes for their preparation
12/10/2009	WO2009147442A1 Novel treatments
12/10/2009	WO2009147441A2 Novel treatments
12/10/2009	WO2009147440A1 Heterocyclic urea derivatives and methods of use thereof
12/10/2009	WO2009147439A1 Anti-tumoural effects of cannabinoid combinations
12/10/2009	WO2009147438A1 Cannabinoids in combination with non -cannabinoid chemotherapeutic agents (e.g. serm or alkylating agents)
12/10/2009	WO2009147434A1 A novel and efficient method for the synthesis of an amino acid
12/10/2009	WO2009147433A1 Heterocyclic urea derivatives for the treatment of bacterial infections
12/10/2009	WO2009147431A1 Thiazolo [5, 4-b] pyridine and oxazolo [5, 4-b] pyridine derivatives as antibacterial agents
12/10/2009	WO2009147430A1 A process for the preparation of enantiomerically pure amines
12/10/2009	WO2009147418A1 Substituted quinazolines
12/10/2009	WO2009147390A1 Medicaments and methods for inhibition of scarring
12/10/2009	WO2009147387A1 A transdermal drug delivery device
12/10/2009	WO2009147383A1 Process for the synthesis of arformoterol
12/10/2009	WO2009147275A1 Use of statins as anticonvulsants, antiepileptics and neuroprotectors
12/10/2009	WO2009147269A1 Topical ibuprofen formulation
12/10/2009	WO2009147238A1 Solid pharmaceutical formulations comprising bibw 2992
12/10/2009	WO2009147229A1 Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon

1 ... 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 ... 7860